Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old [Phase 3]
Phase 3 trial comparing intramuscular SP306 to subcutaneous DT in Japanese adolescents aged 11-12 evaluating vaccines for tetanus, diphtheri…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) [Phase 3]
Phase 3 trial of an investigational V441-001 vaccine in healthy infants in Taiwan has completed, targeting diphtheria, tetanus, pertussis, h…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth [Phase 3]
Phase 3 trial of the DTaP-IPV-HepB-PRP-T pentavalent vaccine in Indian infants completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Database Surveillance Safety Study of PENTACEL® Vaccine
Completed database surveillance safety study evaluating the Pentacel vaccine for safety signals related to its diphtheria, tetanus, pertussi…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants
GlaxoSmithKline-sponsored trial examining risk factors for pertussis infection among infants has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 trial evaluating the DTap-IPV vaccine as the fifth dose in children aged 4 to 6 years, comparing it with DAPTACEL and IPOL; result…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
Follow-up study reports antibody responses to hepatitis B, acellular pertussis toxin, and inactivated poliovirus antigens 1 month after the …
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. [Phase 3]
Phase 3 trial in China evaluating Sanofi Pasteur's Tdap booster vaccine against local diphtheria-tetanus vaccines in children and adolescent…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis [Phase 2]
Phase 2 trial of a combined tetanus, diphtheria, acellular pertussis, and inactivated poliomyelitis vaccine sponsored by Sanofi Pasteur has …
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants [Phase 3]
Phase 3 trial comparing the safety and immunogenicity of Pediacel versus Infanrix IPV+Hib (Penta) given in a 3-dose schedule in infants; the…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® [Phase 3]
Phase 3 trial comparing booster vaccination with Pediacel versus Infanrix Hexa when co-administered with Prevenar in healthy infants has com…
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
A post-authorization safety study evaluating the Euforvac-Hib vaccine for active primary immunization in infants starting at 6 weeks to moni…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years [Phase 1]
Phase 1 safety and dose-ranging study of acellular pertussis vaccine and an acellular pertussis-tetanus-diphtheria booster vaccine in health…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants [Phase 2]
Phase 2 trial of GSK2202083A vaccine in healthy infants completed; multiple conditions tested including tetanus, hepatitis B, Hib, polio, ac…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial assessing safety and immunogenicity of booster doses for new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (GSK217744) in chi…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Pertussis Vaccine in Healthy Pregnant Women [Phase 1]
Phase 1 trial evaluating a pertussis-containing vaccine in healthy pregnant women has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants [Phase 3]
A Phase 3 trial assessed the booster effect of the DTaP-IPV-HepB-PRP-T vaccine (Infanrix Hexa) and Prevenar in healthy infants; results were…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject [Phase 3]
A Phase 3 clinical trial comparing the immunogenicity and safety of Quinvaxem vaccine given in mono-dose vials versus Uniject.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial update on safety and immunogenicity of new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (DTPa-HBV-IPV/Hib, GSK217744).
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 lot-consistency study of the DTaP-IPV-HB-PRP~T vaccine administered at 2-4-6 months in healthy infants has completed; results were…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants [Phase 3]
Phase 3 study evaluating the DTaP-IPV-Hep B-PRP-T vaccine given with Prevenar and Rotarix in healthy Latin American infants; results were po…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers [Phase 3]
Phase 3 safety trial of Infanrix-IPV+Hib vaccine in healthy Vietnamese toddlers completed with results posted
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose [Phase 4]
This Phase 4 study reports immune responses in adults after revaccination with ADACEL (diphtheria, tetanus, and acellular pertussis) vaccine…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China [Phase 1]
Phase 1 study evaluating the ADACEL Tdap booster in healthy adults and children in China has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-Hep B-PRP~T Combined Vaccine with Infanrix Hexa in healthy Peruvian infants; results were posted in 2014.